TTC36 and hepatocellular carcinoma: We found that relatively low level of TTC36 in HCC cells caused significant proliferation inhibitory effects but had less of an impact on TTC36-high expressed HCC cells, which further confirmed that TTC36's role in the maintenance of sorafenib resistance (Fig. 8A-B).